Camrelizumab plus SOX chemotherapy as adjuvant therapy for pathological stage III gastric or gastroesophageal junction adenocarcinoma: a prospective, multicenter, single-arm, phase II trial
卡瑞利珠单抗联合SOX方案化疗作为病理分期为III期的胃或胃食管交界处腺癌的辅助治疗:一项前瞻性、多中心、单臂II期试验
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251355781
Jin, Hailong; Yu, Jiren; Gao, Yuan; Liu, Xiaosun; Xu, Hongtao; Jiang, Haiping; Zhou, Shenkang; Xu, Nong; Zheng, Yulong; Shen, Qianyun; Zhao, Zhicheng; Wu, Dan; Zhang, Qing; Zhu, Kankai